SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-344007
Filing Date
2012-08-08
Accepted
2012-08-08 16:08:20
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d359784d10q.htm 10-Q 403970
2 CERTIFICATION OF CEO d359784dex311.htm EX-31.1 7000
3 CERTIFICATION OF CFO d359784dex312.htm EX-31.2 7051
4 CERTIFICATION OF CEO d359784dex321.htm EX-32.1 4456
5 CERTIFICATION OF CFO d359784dex322.htm EX-32.2 4555
  Complete submission text file 0001193125-12-344007.txt   2209382

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acad-20120630.xml EX-101.INS 231667
7 XBRL TAXONOMY EXTENSION SCHEMA acad-20120630.xsd EX-101.SCH 26295
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acad-20120630_cal.xml EX-101.CAL 35296
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acad-20120630_def.xml EX-101.DEF 129725
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20120630_lab.xml EX-101.LAB 181576
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20120630_pre.xml EX-101.PRE 152162
Mailing Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 121016970
SIC: 2834 Pharmaceutical Preparations